Tarsus to Participate in Upcoming Investor Conference
Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its upcoming participation in the Barclays 27th Annual Global Healthcare Conference. The company's management will engage in a fireside chat scheduled for Tuesday, March 11th at 8:00 a.m. / 11:00 a.m. ET.
Interested parties can access a live webcast of the presentation through the events section of the Tarsus website. A replay of the session will be made available within 48 hours and will remain accessible for a time on the company's website.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha annunciato la sua prossima partecipazione alla 27ª Conferenza Annuale Globale sulla Salute di Barclays. Il management dell'azienda parteciperà a una chiacchierata informale programmata per martedì 11 marzo alle 8:00 / 11:00 ET.
Le parti interessate possono accedere a un webcast dal vivo della presentazione attraverso la sezione eventi del sito web di Tarsus. Una registrazione della sessione sarà disponibile entro 48 ore e rimarrà accessibile per un certo periodo sul sito dell'azienda.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha anunciado su próxima participación en la 27ª Conferencia Anual Global de Salud de Barclays. La dirección de la empresa participará en una charla informal programada para martes 11 de marzo a las 8:00 a.m. / 11:00 a.m. ET.
Las partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de eventos del sitio web de Tarsus. Una repetición de la sesión estará disponible dentro de 48 horas y permanecerá accesible durante un tiempo en el sitio web de la empresa.
타르수스 제약 (NASDAQ: TARS)는 바클레이스 제27회 연례 글로벌 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사 경영진은 3월 11일 화요일 오전 8시 / 오전 11시 ET에 예정된 대담에 참여할 것입니다.
관심 있는 분들은 타르수스 웹사이트의 이벤트 섹션을 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 세션의 재생은 48시간 이내에 제공되며, 회사 웹사이트에서 일정 기간 동안 접근할 수 있습니다.
Tarsus Pharmaceuticals (NASDAQ: TARS) a annoncé sa prochaine participation à la 27ème Conférence Annuelle Mondiale sur la Santé de Barclays. La direction de l'entreprise participera à une discussion informelle prévue pour mardi 11 mars à 8h00 / 11h00 ET.
Les parties intéressées peuvent accéder à un webcast en direct de la présentation via la section événements du site web de Tarsus. Un enregistrement de la session sera disponible dans les 48 heures et restera accessible pendant un certain temps sur le site de l'entreprise.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat seine bevorstehende Teilnahme an der 27. jährlichen globalen Gesundheitskonferenz von Barclays angekündigt. Das Management des Unternehmens wird an einem Kamin-Gespräch teilnehmen, das für Dienstag, den 11. März um 8:00 Uhr / 11:00 Uhr ET geplant ist.
Interessierte Parteien können über den Veranstaltungsbereich der Tarsus-Website auf ein Live-Webcast der Präsentation zugreifen. Eine Wiederholung der Sitzung wird innerhalb von 48 Stunden zur Verfügung stehen und für eine gewisse Zeit auf der Website des Unternehmens zugänglich bleiben.
- None.
- None.
IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th, at 8:00 a.m. / 11:00 a.m. ET.
A live webcast and additional information can be accessed on the events section of the Tarsus website. The replay will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution,
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ
When is Tarsus Pharmaceuticals (TARS) presenting at the Barclays Healthcare Conference 2025?
How can investors watch Tarsus (TARS) presentation at the Barclays Conference?
How long will the TARS Barclays Conference presentation replay be available?